This survey study (n=980) assessed the perspectives of patients with functional neurological disorders (FND) (e.g. multiple sclerosis, stroke) on novel treatments like psychedelic therapoy. 15% of respondents reported using illicit substances to manage their symptoms, with the majority expereincing no or minimal physical and psychological sequale. 46% of respondents reported that they would be willing to try medically supervised psychedelic therapy.
- Published
- Journal
- Journal of Clinical Psychiatry and Clinical Neuroscience
- Authors
- Butler, M., Seynaeve, M., Bao, J., Crawshaw, A., Pick, S., Nicholson, T. R., Rucker, J., Bradley-Westgaurd, A.